CEO @getsalt_ai | Prev: Co-founder/CTO @jamcityHQ and @Myspace | AI enthusiast and tech trend spotter | Problem solver, computer nerd and amateur astronomer
The slowdown hides in the handoffs.
Teams have strong models and plenty of data; momentum slips when coordination lags.
What helps:
- A unified data plane so public and private signals work in the same model paradigm
- An orchestration layer for ensembles, versions, and swaps
- Standard interfaces with lineage and governance across the pipeline
When the system runs like a conductor, context holds and throughput rises.
Where do your handoffs fail?
#LifeSciences #AIInfrastructure #DataPlane #SystemDesign
At Myspace and Jam City, progress followed sound orchestration: Data consistent, interfaces standard, feedback loops tight.
Health follows the same pattern.
When discovery, trials, and care follow the same structure, work moves faster and the results are clearer.
AI adds new levers—a unified data plane to concentrate signals, a focused ensemble tuned to the decision, and orchestration that keeps decisions moving through the pipeline with context intact.
That’s why I'm focused in life sciences. Each gain adds up, creating real impact for real people.
#LifeSciences #HealthTech #AIInfrastructure #SystemDesign #AIinBiotech
Most companies don’t lack AI tools.
They lack the structure to use them well.
New models launch every week. But integrating them into real systems—across data sources, teams, and compliance environments—is still the hard part.
Salt provides that on-ramp.
We’ve built a platform layer that helps teams turn fragmented AI tools into composable, production-ready systems. It sits inside your environment, behind your firewall, and adapts to your use case.
AI evolves fast. Salt makes it operational
#SaltAI #AIInfrastructure #SystemDesign #EnterpriseAI #OrchestrationLayer #AgenticWorkflows
I’ve always leaned toward high-leverage decisions.
Ones that come with risk, but also meaningful outcomes.
That mindset shapes how I build teams too. Across the companies I’ve helped start, the constant has been structure:
– Independent leaders
– Shared vision
– Clear roles
Many of us have worked together for years. That trust lets us move fast without micromanaging. That alignment is embedded.
You see the value of that approach in technical domains too.
Take AI in life sciences. The models are often managed by ML engineers—but the people who actually understand the biology rarely touch the tools.
I’ve seen what happens when that changes.
In one case, researchers working on protein design—experts in spike binding, immunogenicity, toxicity—could finally interact with the models directly. No coding required. They could adjust variables, test changes, and explore outcomes on their own.
That shift turned a months-long back-and-forth into a responsive, real-time loop.. Discovery moved faster because the people with context were finally in control.
That’s the kind of system I aim to build. One where the right people lead, and the infrastructure doesn’t slow them down.
#AIInfrastructure #Leadership #SystemDesign #LifeSciences #AgenticWorkflows #TeamDesign
LLMs are great at language.
They’re still clumsy with logic.
That’s where orchestration comes in—structure that thinks in steps, not just tokens.
#LLMEngineering#AgenticWorkflows#SaltAI
Most AI drug discovery runs in batches.
Generate candidates → analyze outputs → adjust parameters → repeat.
But what if that loop became continuous?
→ generation → analysis → feedback → regeneration → …
With dynamic graphs, discovery can evolve in real time.
You don’t design a fixed path, you build a system that learns and adjusts.
Each new molecule informs the next.
Graph parameters adjust on the fly.
The system learns, step by step, without pausing for resets.
This approach shifts discovery from a fixed sequence to an adaptive process.
A feedback-driven loop that sharpens as it runs.
#AI4Science #DrugDiscovery #LifeSciences #LangGraph #SystemDesign #AutonomousDiscovery
Most platforms are built to validate assumptions. @getsalt_ai is built to challenge them.
That means tight iteration loops—build, measure, learn—not quarterly product planning cycles. You don’t need to be “right” at the start. You need a system that lets domain experts test, tweak, and learn—without waiting on engineering cycles.
In life sciences, that difference shows up in time-to-discovery, in protocol improvements, in workflow ownership.
We don’t assume the model is correct. We assume the user knows something the model doesn’t—yet.
#SaltAI #ProductMindset #BuildMeasureLearn #AIInfrastructure
A recent arXiv study pointed out something I see often: In life sciences, AI results often can’t be reused or verified—and messy, fragmented pipelines make that worse. They also burn more compute than they need to.
Open, orchestrated labs make results traceable, auditable, and connected—so every step is visible, context stays intact, and systems don’t have to start from scratch.
Reproducibility isn’t a nice-to-have. It’s how trust scales.
At @getsalt_ai, we build orchestration that supports open tools and open pipelines—so science moves fast and holds up under pressure.
#OpenAI #Reproducibility #LabAutomation #AIinBiotech #SystemDesign #SaltAI
Speed in drug development doesn’t come from doing more. It comes from better alignment.
Pharma Manufacturing reports that integrating R&D, manufacturing, and supply can shave up to three years off development timelines.
That’s not a tooling win. It’s an synchronization win.
– Clinical and manufacturing in one flow reduces hand-off delays
– End-to-end supply-chain integration preserves materials and data continuity
– Unified project governance keeps teams aligned and decisions transparent
Structure moves science forward. At @getsalt_ai , orchestration is infrastructure.
#SaltAI #ClinicalInfrastructure #LifeSciences #SystemDesign #AIinBiotech
Source: https://t.co/oFAQLt7b8h
The VTX3232 Parkinson’s trial had a familiar problem: too many biomarkers, not enough structure.
Small sample. High noise. Conflicting signals. That’s not a science issue... It’s a systems one.
In CNS and inflammation:
– Biomarkers behave differently
– Metadata slips through cracks
– Information gets lost between input and outcome
The trial didn’t fail on biology. It failed on system design.
#AIinNeuro #ParkinsonsResearch #SystemDesign #AIInfrastructure #SaltAI
In science, losing metadata is like running an assay blindfolded.
You might think you’re measuring X—but without sample IDs, protocol versions, and parameter logs, you’re just guessing.
At @getsalt_ai our orchestration pipelines preserve every detail—so your assays never lose their bearings.
#SystemDesign #SaltAI
I’ve seen teams lose months of assay data in transit—because the pipeline wasn’t built to preserve context. In biopharma, that fragmentation shows up as degraded model outputs and stalled studies.
It’s not about more AI. It’s about pipelines that:
– Enforce metadata tagging for every sample, assay parameter, and protocol version
– Encrypt transfers end-to-end behind your firewall
– Standardize interfaces so tools swap in and out without dropping lineage
Only with those foundations do models deliver—and studies finish—on time.
#DataStrategy #AIinBiotech #SystemDesign
Some trials fail. Others stall.
Breakthroughs run on AI pipelines that enforce protocols, preserve context, and encrypt data end-to-end.
Roche’s June 16, 2025 press release shows success after setbacks isn’t accidental—it comes from a secure, purpose-built system that coordinates every step behind your firewall.
Source: https://t.co/prUpB81oJo
#SaltAI #ParkinsonsResearch
Not every team is running large-scale infrastructure. But with DeepMind’s new AlphaGenome API, high-resolution genomic predictions are now accessible—even without a full stack.
The model delivers single–base-pair predictions for gene expression, splicing, chromatin features, and contact maps—across sequences up to 1 million base pairs.
– Free API access for non-commercial use
– Colab notebooks for fast onboarding
– Well suited for focused variant or region-level analyses
Repo → https://t.co/9swpEF5M30
For smaller labs, academic groups, or early-stage teams, this lowers the threshold for exploring regulatory effects at base-pair resolution.
At Salt AI, we think a lot about what happens after model access—how predictions move securely, stay traceable, and connect back to the science. Tools like this remind us: accessibility is just the first step. Structure is what carries it forward.
Not every team is running large-scale infrastructure. But with DeepMind’s new AlphaGenome API, high-resolution genomic predictions are now accessible—even without a full stack.
The model delivers single–base-pair predictions for gene expression, splicing, chromatin features, and contact maps—across sequences up to 1 million base pairs.
– Free API access for non-commercial use
– Collab notebooks for fast onboarding
– Well suited for focused variant or region-level analyses
Repo → https://t.co/9swpEF5M30
For smaller labs, academic groups, or early-stage teams, this lowers the threshold for exploring regulatory effects at base-pair resolution.
At Salt AI, we think a lot about what happens after model access—how predictions move securely, stay traceable, and connect back to the science. Tools like this remind us: accessibility is just the first step. Structure is what carries it forward.
Imagine securely orchestrating AlphaGenome calls alongside other specialized models—then toggling your configuration to test an alternative splicing predictor or add a new chromatin-state analysis. All tracked with full lineage, like version control for your science.
That’s the value of a purpose-built orchestration layer:
- Infrastructure-agnostic AI pipelines that adapt as your tools evolve
- End-to-end encryption and metadata tagging to keep context intact
- Audit-ready lineage for regulatory and reproducibility standards
At Salt AI, we embed this conductor behind your firewall—linking best-in-class models into a single, coherent pipeline.
Flexibility. Security. Scale. Most teams don’t get all three—unless they start with structure.
We’ve seen this a lot lately:
The board says, “We need an AI strategy.”
And now someone—usually the CTO or R&D lead—is expected to deliver it, fast.
Most platforms pick up after the strategy’s already in place.
Salt starts earlier.
We help teams make sense of what’s happening inside their environment—how models connect, what parameters matter, where things are breaking down.
From there, we build with them.
AI isn’t a single tool. It needs to be custom to the data and needs of the organization.
Salt's nimble orchestration capabilities allow that to happen.
#SaltAI #ExecutiveStrategy #AIEnablement #VisualFirst #SystemDesign
Every sequencing project surfaces thousands of non-coding variants—most never make it past the noise.
Google DeepMind’s new AlphaGenome API changes the game: it delivers single–base-pair resolution predictions across gene expression, splicing, chromatin structure, and contact maps—on DNA sequences up to a million bases long.
For life sciences teams, this reinforces three things:
– Composable AI pipelines outperform one-size-fits-all models
– Metadata-rich orchestration preserves context and lineage at every step
– On-premise, security-first infrastructure is now the baseline for regulated data
At @getsalt_ai, we build the orchestration layer that connects these specialized models—behind your firewall, tuned to your systems, and ready to scale. Think of it as the conductor that keeps every prediction aligned and audit-ready.
Curious what model stacks others are running—what have you integrated recently?